Close menu




June 2nd, 2021 | 08:18 CEST

Adler Modemärkte, Steinhoff, Carnavale Resources: Where gambling pays off and why

  • Investments
Photo credits: pixabay.com

Anyone who has money can speculate. If you have no money, you have to speculate. That is how stock market veteran André Kostolany once put it. But only very few people know what a good speculation is. As a rule, private investors are too late when it comes to promising speculations. Only those who recognize good stocks in time and understand the investment stories behind them can score with speculative stocks in the long term. We outline how this works and what investors should look out for, using three stocks as examples.

time to read: 3 minutes | Author: Nico Popp
ISIN: DE000A1H8MU2 , NL0011375019 , AU000000CAV5

Table of contents:


    Adler Modemärkte: How long will this stock remain hip?

    The Adler Modemärkte share has recently risen significantly. In just four weeks, the value climbed from EUR 0.19 to EUR 1.37 - that's more than 600%. But why did the share rise so much? Adler Modemärkte was already not in the best of shape before the pandemic. The online business was struggling, and in general, the chain was seen more as a shopping destination for older people. Then came the pandemic and the Company slid into insolvency. Under its own responsibility, Adler is planning to escape bankruptcy once again. The proceedings have been underway since January. In the meantime, the signs are pointing to an opening again - the pandemic has weakened. In addition, Adler received a loan of EUR 10 million in May, which would allow the stores to be restocked with merchandise and the business to continue. After all, Adler employs around 3,200 people.

    The fact that the share price has recently risen so much gives hope but is also a warning signal. It is by no means the case that the cow is off the ice for Adler. Although the insolvency under its management offers the Company a variety of opportunities and the loan granted the chance of a fresh start, the situation remains fragile: both at Adler itself and around the pandemic situation, nothing can be ruled out in the medium term. While the relatively old customer base could be a plus for Adler, as they store less online and are more likely to be vaccinated, a new lockdown in the fall could turn the situation for the worse again. Adler's stock was a good speculation, but given the increased price, it is no longer.

    Steinhoff: Anything is possible - but the opposite is too

    The air is also out at Steinhoff. The furniture group from South Africa is facing lawsuits worth billions due to irregularities in its balance sheet. The Company was already on the verge of bankruptcy because of this. For months, investors have been speculating about whether the legal dispute would soon be resolved and a settlement reached. But this settlement is still a long time coming. After a dynamic development, the share is currently trapped between EUR 0.11 and EUR 0.12. Although the share price may surge again, setbacks are likely. Even after positive news, it remains to be seen how profitable the furniture business can be and whether the stock is even much more attractive without litigation.

    Carnavale Resources: Gold, platinum, industrial metals for EUR 9 million

    Unlike Adler Modemärkte or Steinhoff, the Australian Company Carnavale Resources is not a stumbling company. The Australians operate four promising projects in Western Australia around gold, platinum metals, nickel and copper. Thus, in addition to the trend towards gold, the Company also covers the increasing demand from companies around electromobility. The Carnavale Resources share must be considered highly speculative. However, the reason is not the Company's situation but its strategy: Carnavale takes raw material projects under option at low cost, carries out exploration work, and decides whether it is worthwhile to buy the respective project. Based on fixed purchase agreements, the Company can take its time with exploration or push ahead with the purchase, which is easy on the wallet and gives flexibility.

    Carnavale Resources aims to use innovative exploration methods to obtain indications of potential drill targets at an early stage of projects. The smallest particles in soil samples can be analyzed and examined for their origin. Carnavale then uses this information to continue its work. At the Kookynie Gold Project, initial drilling has revealed high-grade grades at 2 meters over 16.25 g/t gold or 2 meters over 3.11 g/t. Further drilling is planned to investigate the structure of the rock between these high-grade areas. Carnavale is operating four projects of different orientations, looking to develop these further in 2021, and valued at only around EUR 9 million; the share can be considered a promising speculative stock.

    Conclusion: Clear business model instead of a unique situation

    While the principle of hope rules at Adler and Steinhoff and the companies are in an exceptional situation, exploring projects at an early stage is part of Carnavale's daily business. In addition, the share has not yet been so clearly discovered by the market. One reason for this could be the high number of shares. Australian companies typically have many shares outstanding, which leads to very low share prices. However, the bottom line is that this is only an optical phenomenon: At EUR 0.004, it is essential to strictly limit orders and give the market time until an order is executed.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Nico Popp

    Nico Popp

    At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories.

    About the author



    Related comments:

    Commented by Carsten Mainitz on October 14th, 2026 | 05:30 CEST

    Tungsten, Weapons and Growth: Almonty, Rheinmetall and Deutz Under Review. Is This an Opportunity in a Megatrend?

    • Tungsten
    • Raw materials
    • Critical raw materials
    • Geopolitics
    • Defence industry
    • Armaments
    • Military
    • Supply chains
    • Investments

    The stock market is not linear. Greed and fear, excessive optimism or excessive scepticism—all of these drive markets. Only the future will tell what is cheap or expensive today. The stocks mentioned above are at precisely this point. Secure supply chains, access to raw materials and defence readiness are high on the agenda of Western governments. These long-term trends play strongly into the hands of defence companies and raw material producers. Almonty, in particular, as a producer of the critical raw material tungsten, holds a leading position in the sector. Where do the greatest opportunities lie for investors now?

    Read

    Commented by Carsten Mainitz on October 14th, 2026 | 05:25 CEST

    Who Profits When Patents Expire? The Billion-Euro Race Between Formycon, Fresenius and Pfizer

    • Biosimilar
    • FDA
    • Milestone
    • Cancer therapy
    • Pharma
    • Patents
    • Investments

    When patent protection for high-revenue biopharmaceuticals expires, a billion-euro market for follow-on products emerges. Michael Sen, head of the German healthcare group Fresenius SE, cites an impressive figure. By 2035, this could generate around EUR 180 billion in revenue. In particular, biosimilars, biotechnologically produced follow-on medicines that are highly similar in composition to the original medicine and equivalent in quality, efficacy and safety, are forecast to grow significantly. Moreover, biosimilars can strengthen competition and reduce treatment costs. Formycon stands out as a pure play. The company recently reached a crucial milestone. The US Food and Drug Administration (FDA) accepted the marketing authorisation application, the first publicly known application of its kind, for FYB206, a biosimilar candidate to the cancer medicine Keytruda, for review. Keytruda generates around USD 32 billion in annual revenue, making it the world's highest-revenue medicine. Fresenius is strengthening its positioning in the biosimilar sector through an acquisition. Pfizer needs new growth drivers. Who is best positioned for the year-end rally?

    Read

    Commented by Matthias Schomber on October 12th, 2026 | 05:24 CEST

    Every Crisis Creates an Opportunity: Nordex Stumbles, Jungheinrich Struggles, and RE Royalties Looks to Have Found a Bottom

    • Investments
    • Trading Opportunity
    • Technical Analysis
    • Rebound

    When market participants suddenly lose their nerve, and industrial heavyweights like Jungheinrich plunge to new multi-year lows despite bulging order books, a key question for private investors, among others, is whether this is a dangerous crisis with further downside ahead or an attractive entry opportunity. Nordex, too, has recently struggled to build on its successes from earlier this year. The share is trapped in a consolidation phase and has now returned to its level from late February, when it broke out upwards on high volume and with a long green weekly candlestick. Is this an attractive entry point for investors desperately seeking stable, high-yield alternatives in the future-oriented renewable energy market? Find out why scepticism could prevail regarding well-known German names and why a pioneer in royalty financing could be on the verge of the next major share price surge following a technical “textbook pattern”.

    Read